Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Grazyna, Lietzau"'
Autor:
Martyna Bayassi-Jakowicka, Grazyna Lietzau, Ewelina Czuba, Cesare Patrone, Przemysław Kowiański
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 5, p 2618 (2022)
Stress and negative emotions evoked by social relationships and working conditions, frequently accompanied by the consumption of addictive substances, and metabolic and/or genetic predispositions, negatively affect brain function. One of the affected
Externí odkaz:
https://doaj.org/article/1938a62f12384749840e567dd0b920dd
Autor:
Fausto Chiazza, Harald Tammen, Hiranya Pintana, Grazyna Lietzau, Massimo Collino, Thomas Nyström, Thomas Klein, Vladimer Darsalia, Cesare Patrone
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-13 (2018)
Abstract Background Dipeptidyl peptidase-4 (DPP-4) inhibitors (gliptins) are approved drugs for the treatment of hyperglycemia in patients with type 2 diabetes. These effects are mainly mediated by inhibiting endogenous glucagon-like peptide-1 (GLP-1
Externí odkaz:
https://doaj.org/article/8aea2e3d84d74e568768d9f7012ce3f9
Autor:
Martyna Bayassi-Jakowicka, Grazyna Lietzau, Ewelina Czuba, Aleksandra Steliga, Monika Waśkow, Przemysław Kowiański
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 18, p 9806 (2021)
A growing body of evidence suggests that nucleus accumbens (NAc) plays a significant role not only in the physiological processes associated with reward and satisfaction but also in many diseases of the central nervous system. Summary of the current
Externí odkaz:
https://doaj.org/article/b2dcb357b1dc4c7389493c23a3598cf9
Autor:
Vladimer Darsalia, Odd Erik Johansen, Grazyna Lietzau, Thomas Nyström, Thomas Klein, Cesare Patrone
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Cerebral stroke is a leading cause of death and persistent disability of elderly in the world. Although stroke prevention by targeting several risk factors such as diabetes and hypertension has decreased the stroke incidence, the total number of stro
Externí odkaz:
https://doaj.org/article/644eaad974d746899b7d4c74e8260257
Autor:
Grazyna Lietzau, Waldemar Sienkiewicz, Zbigniew Karwacki, Jerzy Dziewiątkowski, Jerzy Kaleczyc, Przemysław Kowiański
Publikováno v:
Molecular Neurobiology.
Statins are lipid-lowering drugs that act by inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase, a rate-limiting enzyme in cholesterol biosynthesis. Animal studies have shown neuroprotective effects of statins in cerebral stroke. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59cbd840231f227f3d9dd9e2d747a269
https://doi.org/10.1007/s12035-023-03371-2
https://doi.org/10.1007/s12035-023-03371-2
Publikováno v:
Folia Morphologica. 80:766-775
The dynamic development of studies on neuroglia in recent years indicates its previously underestimated role in maintaining proper brain function, both in physiological and pathological conditions. The use of modern research methods such as single-ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08937180d6cb2ad1663c03e427d9f8c6
https://doi.org/10.5603/fm.a2021.0109
https://doi.org/10.5603/fm.a2021.0109
Autor:
Grazyna Lietzau, Vladimer Darsalia, Thomas Klein, Camilla Krizhanovskii, Hiranya Pintana, Thomas Nyström, Stelia Ntika, Linda Tracy, Cesare Patrone
Publikováno v:
Cellular and Molecular Neurobiology. 42:1995-2002
Glucagon-like peptide-1 (GLP-1) is a peripheral incretin and centrally active peptide produced in the intestine and nucleus tractus solitarii (NTS), respectively. GLP-1 not only regulates metabolism but also improves cognition and is neuroprotective.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c6b42e14573adb30f7317b68dc971f
https://doi.org/10.1007/s10571-021-01079-2
https://doi.org/10.1007/s10571-021-01079-2
Publikováno v:
Journal of chemical neuroanatomy. 127
Brain injury triggers a complex response involving morphological changes, cellular proliferation, and differentiation of newly formed neuroglial subpopulations. These processes have been extensively studied in animal stroke models with permanent larg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e6653eb142b8b5e6deaa48a823f2a72
https://pubmed.ncbi.nlm.nih.gov/36403746
https://pubmed.ncbi.nlm.nih.gov/36403746
Autor:
Shiva Mansouri, Grazyna Lietzau, Mathias Lundberg, David Nathanson, Thomas Nyström, Cesare Patrone
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156867 (2016)
Hypoglycaemia is a common side-effect of glucose-lowering therapies for type-2 diabetic patients, which may cause cognitive/neurological impairment. Although the effects of hypoglycaemia in the brain have been extensively studied in neurons, how hypo
Externí odkaz:
https://doaj.org/article/bb4dfc8a1f6c4391b6e9a8f737e327f3
Publikováno v:
ACS Chemical Neuroscience
Olfactory dysfunction could be an early indicator of cognitive decline in type 2 diabetes (T2D). However, whether obesity affects olfaction in people with T2D is unclear. This question needs to be addressed, because most people with T2D are obese. Im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60b6ae00c40ded862fc801614d300158
https://doi.org/10.1021/acschemneuro.0c00466
https://doi.org/10.1021/acschemneuro.0c00466